养肝活血清利法治疗失代偿性肝硬化临床研究

A study on treating decompensated liver cirrhosis by the Yanggan Huoxue Qingli therapy

目的:养肝活血清利法用于失代偿性肝硬化患者的临床疗效。方法:回顾性分析我院收治的肝硬化患者48例,分为对照组和观察组各24例,对照组给予常规保肝、对症治疗,观察组在常规治疗基础上加用养肝活血清利法治疗。结果:给予两组不同治疗后,观察组总有效率为83.3%,高于对照组的62.5%;无效率为16.7%,低于对照组的37.5%,P<0.05,显示差异有统计学意义。结论:养肝活血清利法治疗失代偿期肝硬化效果显著,该疗法满意度较高,值得深入研究和推广使用。

Objective： To treat decompensated liver cirrhosis by the Yanggan Huoxue Qingli therapy. Methods： 48 patients were divided into the control group and observed group with 24 cases in each, the control group was treated with routine and symptomatic treatment, the observed group was given more the Huoxue Qingli therapy. Results： After treatment, the total efficiency in observed group 83.3% was higher than 62.5%, invalid 16.7% less than 37.5%. There was statistically significant difference （P〈0.05）. Conclusion： Decompensated cirrhosis was treated by the Yanggan Huoxue Qingli therapy can show significant effects and more satisfaction. It is worthy of further research and promotion.